Skip to main content
Signal8
Verjee Rehan profile photo

Rehan Verjee

CIK: 0001880637

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Tyra Biosciences, Inc. logo
TYRA

Tyra Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Tyra Biosciences, Inc. logo
    TYRA

    Tyra Biosciences, Inc.

    Sep 9, 2026
    Purchase(P)
    Direct
    972 shares at avg. $20.58$20K
  • Tyra Biosciences, Inc. logo
    TYRA

    Tyra Biosciences, Inc.

    May 28, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    13.2K shares-
  • Tyra Biosciences, Inc. logo
    TYRA

    Tyra Biosciences, Inc.

    May 29, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    22.2K shares-

1-3 of 3

About Verjee Rehan

Verjee Rehan (SEC CIK 0001880637) files insider reports with the SEC as Director of Tyra Biosciences, Inc. (TYRA).

Signal8 holds 3 ownership filings by Verjee Rehan, all Form 4s, filed between Jun 2, 2025 and Sep 11, 2026. Those filings report 3 transactions, from May 29, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Verjee Rehan's filings is in CARLSBAD, CA.

Recent filings by Verjee Rehan

  • Sep 9, 2026: Open-market purchase of TYRA shares (Form 4, code P).
  • May 28, 2026: Grant or award of TYRA derivative securities (Form 4, code A).
  • May 29, 2025: Grant or award of TYRA derivative securities (Form 4, code A).

Other insiders filing for Tyra Biosciences, Inc. (TYRA)

How to read Form 4 transaction codes